Bluesky’s less formal and more community-driven environment also offers an opportunity for experimentation. Unlike X, where ...

Pharmacists in Nigeria have revealed that low investment and interest in drug and vaccine manufacturing persist because ...

Johnson & Johnson has rewarded shareholders with a quarterly dividend. As a Dividend King, it is the epitome of a steady and ...

Genentech’s label expansion for TNKase consolidates its market position for pharmacological stroke treatments.

The UK must increase investment in innovative medicines and vaccines if it is to deliver on the NHS 10-Year Plan and drive ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

A Senate committee this week will almost surely push forward the FDA and NIH nominees. Neither one has the public interest at ...

The changes at Spark follow Roche's decision last year to halt development of a gene therapy for hemophilia A that was the ...

Micreos Pharmaceuticals AG (”Micreos”), a preclinical-stage biopharmaceutical company, specializing in developing Engineered ...

Jefferies backs Lupin, Zydus, and Biocon amid shifting US pharma market shares. Discover why these stocks are set to shine.

Following a year of strategic expansion, European medicine-related companies are advancing their operations in Vietnam.

The high street chemist was caught selling Wegovy – a prescription-only drug – to a 16-year-old undercover reporter ...